NM_020682.4:c.610+63T>C

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_Strong

The NM_020682.4(AS3MT):c.610+63T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.25 (AC=370,792) in the gnomAD database across 1,481,194 control chromosomes, including 47,616 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.313. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.25 ( 4724 hom., cov: 32)
Exomes 𝑓: 0.25 ( 42892 hom. )

Consequence

AS3MT
NM_020682.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.31

Publications

32 publications found
Variant links:
Genes affected
AS3MT (HGNC:17452): (arsenite methyltransferase) AS3MT catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (AdoMet) to trivalent arsenical and may play a role in arsenic metabolism (Lin et al., 2002 [PubMed 11790780]).[supplied by OMIM, Mar 2008]
BORCS7-ASMT (HGNC:49183): (BORCS7-ASMT readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring C10orf32 (chromosome 10 open reading frame 32) and AS3MT (arsenic, +3 oxidation state, methyltransferase) genes. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is therefore unlikely to produce a protein product. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_020682.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -4 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.313 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_020682.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

AS3MT NM_020682.4
MANE Select
HGVSc / HGVSpc.610+63T>C
Exon rankIntron 7 of 10
intron
Prot: NP_065733.2UniProt: Q9HBK9-1
BORCS7-ASMT NR_037644.1
HGVSc / HGVSpn.1015+63T>C
Exon rankIntron 11 of 14
intron
Prot:

Ensembl Transcripts

AS3MT ENST00000369880.8
TSL:1MANE Select
HGVSc / HGVSpc.610+63T>C
Exon rankIntron 7 of 10
intron
Prot: ENSP00000358896.3UniProt: Q9HBK9-1
BORCS7-ASMT ENST00000299353.6
TSL:5
HGVSc / HGVSpn.*617+63T>C
Exon rankIntron 11 of 14
intron
Prot: ENSP00000299353.5UniProt: Q96B45
AS3MT ENST00000942423.1
HGVSc / HGVSpc.595+63T>C
Exon rankIntron 7 of 10
intron
Prot: ENSP00000612482.1UniProt: A0ACI8U690

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.246
AC:37439
Hom:4722
AN:152114
Cov:32
GnomAD4 exome
AF: 0.251
AC:333342
Hom:42892
AN:1328962
GnomAD4 genome
AF: 0.246
AC:37450
Hom:4724
AN:152232
Cov:32
TOPMed (Bravo)
AF: 0.245
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.257
AC:33120
Hom:4309
AN:128810
Local & regional cohorts 9 sources
ABraOM SABE-WGS-1171
AF: 0.254
AC:594
Hom:84
AN:2342
ChinaMAP Phase 1
AF: 0.294
Denmark Genome
AF: 0.253
AC:76
AN:300
GenomeAsia100K
AF: 0.242
AC:840
AN:3478
Korea4K (4,157 Koreans)
AF: 0.241
AC:1747
AN:7234
Qatari Genome
AF: 0.301
AC:53
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.186
AC:22780
Hom:2217
AN:122684
UK10K
AF: 0.248
AC:1876
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.309
AC:2766
Hom:426
AN:8960
Showing 14 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.192 1294967534 0.202 26674132192
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign4.1
BayesDel_noAF
Benign-0.85
CADD
Benign6.3
DANN
Benign0.72
GPN-Star LLR
N/A0.085
GPN-Star score
N/A-0.085
PhyloP100
Benign1.3
Showing 7 of 7 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.